Stockmeier, Craig A.

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression

eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics

Genetic Associations and EpidemiologyTreatment of Major Depression

Cited by 3,005

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗∗See accompanying Editorial, in this issue.

Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry

Treatment of Major DepressionNeural and Behavioral Psychology Studies

Cited by 1,477

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder

Kang, H. J., Voleti, B., Hajszan, T., Rajkowska, G., Stockmeier, C. A., Licznerski, P., Lepack, A., Majik, M. S., Jeong, L. S., Banasr, M., et al. (2012) · Nature Medicine

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 808

Cellular changes in the postmortem hippocampus in major depression

Stockmeier, C. A., Mahajan, G. J., Konick, L. C., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., Uylings, H. B. M., Friedman, L., & Rajkowska, G. (2004) · Biological Psychiatry

Treatment of Major DepressionStress Responses and Cortisol

Cited by 732

Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue

Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 603

GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major Depression

Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., & Miguel-Hidalgo, J. J. (2007) · Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 430

Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression

Feyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 421

A negative regulator of MAP kinase causes depressive behavior

Duric, V., Banasr, M., Licznerski, P., Schmidt, H. D., Stockmeier, C. A., Simen, A. A., Newton, S. S., & Duman, R. S. (2010) · Nature Medicine

Treatment of Major DepressionProtein Tyrosine Phosphatases

Cited by 412

The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder

Jernigan, C. S., Goswami, D. B., Austin, M. C., Iyo, A. H., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 386

Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies

Perry, D. C., Dávila-Garcı́a, M. I., Stockmeier, C. A., & Kellar, K. J. (1999) · The Journal of Pharmacology and Experimental Therapeutics

Nicotinic Acetylcholine Receptors StudySmoking Behavior and Cessation

Cited by 362

Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects

Duric, V., Banasr, M., Stockmeier, C. A., Simen, A. A., Newton, S. S., Overholser, J. C., Jurjus, G. J., Dieter, L., & Duman, R. S. (2013) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 304

Reduced Metabotropic Glutamate Receptor 5 Density in Major Depression Determined by [11C]ABP688 PET and Postmortem Study

Deschwanden, A., Karolewicz, B., Feyissa, A. M., Treyer, V., Ametamey, S. M., Johayem, A., Burger, C., Auberson, Y. P., Sovago, J., Stockmeier, C. A., et al. (2011) · American Journal of Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 278

REDD1 is essential for stress-induced synaptic loss and depressive behavior

Ota, K. T., Liu, R.-J., Voleti, B., Maldonado-Aviles, J. G., Duric, V., Iwata, M., Dutheil, S., Duman, C., Boikess, S., Lewis, D. A., et al. (2014) · Nature Medicine

Treatment of Major DepressionStress Responses and Cortisol

Cited by 267

Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder

Cobb, J. A., O’Neill, K., Milner, J., Mahajan, G. J., Lawrence, T. J., May, W. L., Miguel-Hidalgo, J., Rajkowska, G., & Stockmeier, C. A. (2016) · Neuroscience

Treatment of Major DepressionStress Responses and Cortisol

Cited by 254

Glial and glutamatergic markers in depression, alcoholism, and their comorbidity

Miguel-Hidalgo, J. J., Waltzer, R., Whittom, A. A., Austin, M. C., Rajkowska, G., & Stockmeier, C. A. (2010) · Journal of Affective Disorders

Neuroscience and Neuropharmacology ResearchTreatment of Major Depression

Cited by 218

Coverage of Blood Vessels by Astrocytic Endfeet Is Reduced in Major Depressive Disorder

Rajkowska, G., Hughes, J., Stockmeier, C. A., Javier Miguel-Hidalgo, J., & Maciag, D. (2013) · Biological Psychiatry

Barrier Structure and Function StudiesTreatment of Major Depression

Cited by 209

Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression

Karolewicz, B., Maciag, D., O'Dwyer, G., Stockmeier, C. A., Feyissa, A. M., & Rajkowska, G. (2010) · The International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 203

Apples to oranges?: A direct comparison between suicide attempters and suicide completers

DeJong, T. M., Overholser, J. C., & Stockmeier, C. A. (2010) · Journal of Affective Disorders

Suicide and Self-Harm StudiesHomicide, Infanticide, and Child Abuse

Cited by 198

Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia

Bryois, J., Garrett, M. E., Song, L., Safi, A., Giusti-Rodriguez, P., Johnson, G. D., Shieh, A. W., Buil, A., Fullard, J. F., Roussos, P., et al. (2018) · Nature Communications

Schizophrenia research and treatmentGenomics and Chromatin Dynamics

Cited by 167

Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression

Zhu, M.-Y., Klimek, V., Dilley, G. E., Haycock, J. W., Stockmeier, C., Overholser, J. C., Meltzer, H. Y., & Ordway, G. A. (1999) · Biological Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 137

Elevated Concentrations of CRF in the Locus Coeruleus of Depressed Subjects

Bissette, G., Klimek, V., Pan, J., Stockmeier, C., & Ordway, G. (2003) · Neuropsychopharmacology

Stress Responses and CortisolNeuropeptides and Animal Physiology

Cited by 136

Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder

Szewczyk, B., Albert, P. R., Burns, A. M., Czesak, M., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., Konick, L. C., Dieter, L., Herbst, N., et al. (2009) · The International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 87

Venlafaxine Stimulates an MMP-9-Dependent Increase in Excitatory/Inhibitory Balance in a Stress Model of Depression

Alaiyed, S., McCann, M., Mahajan, G., Rajkowska, G., Stockmeier, C. A., Kellar, K. J., Wu, J. Y., & Conant, K. (2020) · The Journal of Neuroscience

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 84

Cellular abnormalities in depression: evidence from postmortem brain tissue

Stockmeier, C. A., & Rajkowska, G. (2004) · Dialogues in Clinical Neuroscience

Treatment of Major DepressionStress Responses and Cortisol

Cited by 67